Curis
CRIS
#10186
Rank
S$16.74 M
Marketcap
S$1.22
Share price
-5.93%
Change (1 day)
-67.85%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): S-$4.87

According to Curis's latest financial reports the company's current EPS (TTM) is S-$4.71. In 2024 the company made an earnings per share (EPS) of S-$9.02 an increase over its 2023 EPS that were of S-$11.59.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$4.87-45.97%
2024S-$9.02-22.15%
2023S-$11.59-26.17%
2022S-$15.6922.3%
2021S-$12.83-25.37%
2020S-$17.19-30.93%
2019S-$24.89-2.02%
2018S-$25.41
2016S-$57.74-10%
2015S-$64.16138.1%
2014S-$26.9540%
2013S-$19.25-25%
2012S-$25.6666.67%
2011S-$15.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$1.75-137.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$3.81-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
S-$0.46-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$3.05-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S-$4.34-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S-$14.42 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$1.81-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA